Literature DB >> 6437267

End-tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia.

L Baudendistel, N Goudsouzian, C Cote', M Strafford.   

Abstract

Two cases of malignant hyperthermia are described where the earliest sign was a rise in the end-tidal CO2 concentration. This led to nearly immediate detection and adequate treatment with sodium dantrolene. These cases demonstrate the efficacy of monitoring end-expired CO2 concentrations in patients at risk from malignant hyperthermia, as well as a means for following the adequacy of treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437267     DOI: 10.1111/j.1365-2044.1984.tb08889.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  End-tidal carbon dioxide concentration, carbon dioxide production, heart rate, and blood pressure as indicators of induced hyperthermia.

Authors:  V de las Alas; W D Voorhees; L A Geddes; J D Bourland; W E Schoenlein
Journal:  J Clin Monit       Date:  1990-07

Review 2.  Capnometry and anaesthesia.

Authors:  K Bhavani-Shankar; H Moseley; A Y Kumar; Y Delph
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

3.  Intraoperative events diagnosed by expired carbon dioxide monitoring in children.

Authors:  C J Coté; L M Liu; S K Szyfelbein; S Firestone; N G Goudsouzian; J P Welch; A L Daniels
Journal:  Can Anaesth Soc J       Date:  1986-05

4.  Development of malignant hyperthermia obscured by cardiopulmonary bypass.

Authors:  R G MacGillivray; H Jann; E Vanker; L Gemmell; A E Mahomedy
Journal:  Can Anaesth Soc J       Date:  1986-07

Review 5.  Practical CO2 monitoring in anaesthesia.

Authors:  R L Knill
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

Review 6.  Malignant hyperthermia.

Authors:  R Ben Abraham; P Adnet; V Glauber; A Perel
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

Review 7.  Temperature monitoring and perioperative thermoregulation.

Authors:  Daniel I Sessler
Journal:  Anesthesiology       Date:  2008-08       Impact factor: 7.892

8.  A suspected malignant hyperthermia managed without dantrolene sodium.

Authors:  Bon-Sung Koo; Young-Kwon Kim; Sang-Hyun Kim; Jeong-Seok Lee; Yong-Ik Kim
Journal:  Korean J Anesthesiol       Date:  2014-12

9.  A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome.

Authors:  Yoshiki Hara; Yutaka Hosoya; Ryo Deguchi; Shigehito Sawamura
Journal:  JA Clin Rep       Date:  2016-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.